Nova Eye Medical (EYE) Discussion, page-3186

yes this won’t impact MIGS even it become it more common use as a first step and then patient needs MIGS as they worsen.

I do really think though it shows there is big money in eye health M&A even for solutions which help a proportion of patients and or provide some more longevity without solving the problem.

obviously M&A activity continues behind the scenes so who knows if anyone is running the numbers on 2RT. It seems to be taking. Very long time to me but he again this laser they have bought has been around 7 years or so from some initial searches since they were announcing phase 2 trial results so things done seem to happen in a rush in this space.

what would EYE be worth if they announced a 2RT deal with same metrics/ $80m upfront and $385m+ total further payments? Could 10 bag the same day.

https://en.globes.co.il/en/article-alcon-completes-acquisition-of-israeli-co-belkin-vision-1001483416